Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

China’s NMPA approves Novartis’ Cosentyx and Merck’s Keytruda

pharmaceutical-technologyApril 23, 2019

Tag: china , NMPA , Cosentyx , Merck , Keytruda

PharmaSources Customer Service